某院门诊心血管类中成药的应用情况及趋势分析  

Application and Trend Analysis of Cardiovascular Chinese Patent Medi⁃cines in Outpatient Clinics in A Hospital

作　　者：闫翠 YAN Cui(Department of Pharmacy,Xuzhou Hospital of Traditional Chinese Medicine,Xuzhou,Jiangsu Province,221003 China)

机构地区：[1]徐州市中医院药剂科,江苏徐州221003

出　　处：《系统医学》2022年第11期182-184,198,共4页Systems Medicine

摘　　要：目的分析心血管类中成药的应用现状及用药趋势。方法本研究于2020年1月—2021年12月以徐州市中医院心血管科室开具的4000张处方作为研究数据,其中2020年度共收集2000张处方,2021年共收集2000张处方,通过统计销售量、销售金额、频度分析等措施对本院门诊常用的部分口服心血管类中成药进行分析。结果2020年的2000张心血管科处方中,麝香保心丸、脑心通胶囊、复方丹参滴丸、稳心颗粒、通心络胶囊、血塞通滴丸这6种中成药用药频度(DDDs)分别为6011.25、3262.04、2238.00、636.00、729.47、2100.00;日均费用(DDDc)分别为3.41、5.97、4.35、7.74、8.35、7.03元,排序比范围为0.75~1.33。在2021年,上述6种中成药DDDs值分别为6171.77、3296.97、2574.00、828.00、778.85、2231.25;DDDc值分别为3.56、6.03、4.35、7.74、9.15、8.03元,排序比范围为0.75~1.33。该6种中成药的销售量、销售金额、用药频度均呈现上升趋势,部分中成药的DDDc值也有所上升。结论通过统计心血管类中成药的DDDs、DDDc值和排序比,可有效评价药物使用的合理性与经济性,6种中成药的使用均较为合理,其中麝香保心丸最具经济性特点,药品总体使用频度和销售量增加,加强合理用药是控制中成药应用趋势的重要途径。Objective To analyze the application status and medication trend of cardiovascular Chinese patent medi⁃cines.Methods From January 2020 to December 2021,and 4000 prescriptions issued by the cardiovascular depart⁃ment of Xuzhou Hospital of Traditional Chinese Medicine were used as the study data.Among them,a total of 2000 prescriptions were collected in 2020,and a total of 2000 prescriptions were collected in 2021.Through the statistics of sales volume,sales amount,frequency analysis and other measures,some oral cardiovascular Chinese patent medi⁃cines commonly used in outpatient clinics in the hospital were analyzed.Results Among the 2000 cardiovascular prescriptions in 2020,the frequency of use of six Chinese patent medicines(Shexiang Baoxin Pills,Naoxintong Cap⁃sules,Fufang Danshen Dropping Pills,Wenxin Granules,Tongxinluo Capsules,and Xuesaitong Dropping Pills)(DDDs)were 6011.25,3262.04,2238.00,636.00,729.47,2100.00,respectively.The average daily cost(DDDc)was 3.41,5.97,4.35,7.74,8.35,7.03 yuan,and the ranking ratio range was 0.75~1.33.In 2021,the DDDs values of the above six proprietary Chinese medicines were 6171.77,3296.97,2574.00,828.00,778.85,2231.25,respec⁃tively;the DDDc values were 3.56,6.03,4.35,7.74,9.15,8.03 yuan,respectively,and the ranking ratio range 0.75~1.33.The sales volume,sales amount,and medication frequency of the six Chinese patent medicines all showed an upward trend,and the DDDc values of some Chinese patent medicines also increased.Conclusion By counting the DDDs,DDDc values and ranking ratios of cardiovascular Chinese patent medicines,the rationality and economy of drug use can be effectively evaluated.The use of six Chinese patent medicines is reasonable,and Shexiang Baoxin Pill is the most economical.The overall use frequency and sales volume of drugs have increased,and strengthening rational drug use is an important way to control the application trend of Chinese patent medicines.

关 键 词：心血管类中成药 用药趋势 用药频度 日均费用 

分 类 号：R54[医药卫生—心血管疾病]